1. AB0774 TIME TO RESPONSE FOR CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB, ADALIMUMAB OR PLACEBO. (2nd June 2020) Authors: Gladman, D. D.; Coates, L. C.; Wu, J.; Fallon, L.; Hsu, M. A.; Bushmakin, A. G.; Bacci, E.; Cappelleri, J. C.; Helliwell, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0837 ITCH AS THE MAJOR MEDIATOR OF THE EFFECT OF TOFACITINIB ON HEALTH-RELATED QUALITY OF LIFE IN PsA: A MEDIATION ANALYSIS. (2nd June 2020) Authors: Taylor, P. C.; Bushmakin, A. G.; Cappelleri, J. C.; Young, P.; Germino, R.; Merola, J. F.; Yosipovitch, G. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0838 IDENTIFYING MEDIATORS OF PAIN REDUCTION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION ASSOCIATED WITH PERIPHERAL ARTHRITIS, ENTHESITIS AND SKIN DISEASE. (2nd June 2020) Authors: Taylor, P. C.; De Vlam, K.; Bushmakin, A. G.; Fallon, L.; Merola, J. F.; Cappelleri, J. C.; Hsu, M. A.; Mease, P. J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin. Issue 1 (13th December 2012) Authors: Bushmakin, A. G.; Cappelleri, J. C.; Chandran, A. B.; Zlateva, G. Journal: International journal of clinical practice Issue: Volume 67:Issue 1(2013) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0396 HOW DOES OSTEOARTHRITIS PAIN IMPACT FUNCTION, MOBILITY AND REQUIREMENT FOR HELP IN DAILY ACTIVITIES IN EUROPEAN PATIENTS?. (13th June 2020) Authors: Conaghan, P. G.; Abraham, L.; Graham-Clarke, P.; Viktrup, L.; Cappelleri, J. C.; Beck, C.; Bushmakin, A. G.; Hatchell, N.; Clayton, E.; Jackson, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0397 THE IMPACT OF OSTEOARTHRITIS DISEASE SEVERITY ON HEALTHCARE RESOURCE USE: ANALYSIS OF REAL-WORLD EUROPEAN DATA. (13th June 2020) Authors: Conaghan, P. G.; Abraham, L.; Graham-Clarke, P.; Viktrup, L.; Cappelleri, J. C.; Beck, C.; Bushmakin, A. G.; Hatchell, N.; Clayton, E.; Jackson, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0190 UNDERSTANDING CURRENT PRESCRIPTION DRUG TREATMENT PARADIGMS FOR PATIENTS WITH OSTEOARTHRITIS IN EUROPE. (2nd June 2020) Authors: Conaghan, P. G.; Abraham, L.; Graham-Clarke, P.; Viktrup, L.; Cappelleri, J. C.; Beck, C.; Bushmakin, A. G.; Hatchell, N.; Clayton, E.; Jackson, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗